Healthcare -
Biotechnology - NASDAQ - US
$ 15.6
-1.27 %
$ 99.7 M
Market Cap
-0.95
P/E
FBRX - COST OF REVENUE
Cost of Revenue FBRX - Forte Biosciences, Inc.
9 K
LAST VALUE
-50.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR